Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus
about
A dual-mode surface display system for the maturation and production of monoclonal antibodies in glyco-engineered Pichia pastorisIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitnessGeneration of an intrabody-based reagent suitable for imaging endogenous proliferating cell nuclear antigen in living cancer cells.Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5.Reconstitution of the receptor-binding motif of the SARS coronavirus.Antibody affinity maturation through combining display of two-chain paired antibody and precision flow cytometric sorting.Severe acute respiratory syndrome: a vanished evil?Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.Binding affinity prediction of nanobody-protein complexes by scoring of molecular dynamics trajectories.Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
P2860
Q28534600-B0E2092A-967F-49C7-AE6C-11287173EA04Q33627189-26CEEA78-7BF7-4746-BABD-62F56F2227ACQ34594139-DFD59B36-AED6-4588-96DC-779300567C4DQ35209715-4D783C9F-D3E2-4E47-B2E9-E78A8F2CCD61Q35624791-18DF763B-016F-496B-9D21-83BE686D26B2Q35815644-8C72D0E0-8C91-4C80-B526-B9DE8E1D973EQ36007852-9B087998-FFAE-4B8F-8931-7CE051736955Q37105513-B6D6C518-46CD-45EF-9477-06C4BCAB7FB0Q37169882-2E82AE1F-B05A-4229-AB7E-FF26BDEC53AAQ38098075-B9F46574-6936-41F3-970E-9ADABA783417Q39312261-92BBA58C-33E1-4DB3-92F5-7AB7042038E4Q41619358-BA7AFF8E-FECC-465F-AB0C-A8346DC10ED9Q50068363-D2931C74-9D35-4C3E-A73E-4177A49FC17CQ51783750-51A579BC-153B-40D9-BDF7-72875F567525
P2860
Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Increased antibody affinity co ...... spiratory syndrome coronavirus
@ast
Increased antibody affinity co ...... spiratory syndrome coronavirus
@en
type
label
Increased antibody affinity co ...... spiratory syndrome coronavirus
@ast
Increased antibody affinity co ...... spiratory syndrome coronavirus
@en
prefLabel
Increased antibody affinity co ...... spiratory syndrome coronavirus
@ast
Increased antibody affinity co ...... spiratory syndrome coronavirus
@en
P2093
P2860
P356
P1433
P1476
Increased antibody affinity co ...... spiratory syndrome coronavirus
@en
P2093
Brent Iverson
Eric F Donaldson
George Georgiou
Meagan Bolles
Mridula Rani
Thomas Van Blarcom
P2860
P304
P356
10.1128/JVI.00233-12
P407
P577
2012-06-13T00:00:00Z